Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation (Q42803719)

7 November 2017

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation (English)

1 reference

7 November 2017

Hauser S

1

1 reference

7 November 2017

Adelmant G

2

1 reference

7 November 2017

Sarraf P

3

1 reference

7 November 2017

Wright HM

4

1 reference

7 November 2017

Mueller E

5

1 reference

7 November 2017

Spiegelman BM

6

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Journal of Biological Chemistry

7 November 2017

1 reference

7 November 2017

275

1 reference

7 November 2017

18527-18533

1 reference

7 November 2017

24

1 reference

Transcriptional activation of adipogenesis

7 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Interdomain communication regulating ligand binding by PPAR-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

The ubiquitin-proteasome pathway: on protein death and cell life

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Substrate targeting in the ubiquitin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Implication of proteasome in estrogen receptor degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Proteasome-dependent degradation of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

p300/MDM2 complexes participate in MDM2-mediated p53 degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Sublines of mouse 3T3 cells that accumulate lipid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M001297200

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

15 July 2023

Identifiers

DOI

10.1074/JBC.M001297200

1 reference

7 November 2017

1 reference